See more : Vinergy Capital Inc. (VNNYF) Income Statement Analysis – Financial Results
Complete financial analysis of ZhuZhou QianJin Pharmaceutical Co.,Ltd (600479.SS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of ZhuZhou QianJin Pharmaceutical Co.,Ltd, a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- AutoZone, Inc. (AZO) Income Statement Analysis – Financial Results
- Unique Opto-Electronics Co.,Ltd. (3441.TWO) Income Statement Analysis – Financial Results
- Miton UK MicroCap Trust plc (MINI.L) Income Statement Analysis – Financial Results
- PT Ulima Nitra Tbk (UNIQ.JK) Income Statement Analysis – Financial Results
- Sanistål A/S (SANI.CO) Income Statement Analysis – Financial Results
ZhuZhou QianJin Pharmaceutical Co.,Ltd (600479.SS)
About ZhuZhou QianJin Pharmaceutical Co.,Ltd
ZhuZhou QianJin Pharmaceutical Co.,Ltd produces and sells pharmaceutical products in China. The company provides gynecology, pediatrics, beauty, antimicrobial, circulatory, endocrine, specialty, digestive, nervous, and cardiovascular products, as well as traditional Chinese medicines It offers its products in various forms, including tablets, capsules, granules, pills, decoctions, powders, and solution. The company also provides ginger tea; feminine hygiene products; and wine. ZhuZhou QianJin Pharmaceutical Co.,Ltd was founded in 1993 and is headquartered in Zhuzhou, China.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 3.80B | 4.03B | 3.66B | 3.63B | 3.53B | 3.33B | 3.18B | 2.86B | 2.45B | 2.19B | 1.97B | 1.58B | 1.26B | 979.44M | 904.27M | 801.43M | 679.78M | 602.69M | 665.83M | 604.93M | 686.80M | 582.03M | 560.21M |
Cost of Revenue | 2.05B | 2.29B | 2.03B | 2.03B | 1.92B | 1.78B | 1.74B | 1.57B | 1.31B | 1.14B | 1.01B | 786.31M | 603.54M | 427.85M | 360.83M | 345.79M | 322.31M | 309.37M | 423.79M | 409.40M | 476.10M | 405.90M | 417.28M |
Gross Profit | 1.75B | 1.74B | 1.63B | 1.60B | 1.61B | 1.55B | 1.44B | 1.29B | 1.14B | 1.05B | 966.04M | 797.11M | 652.99M | 551.59M | 543.44M | 455.64M | 357.47M | 293.32M | 242.03M | 195.53M | 210.70M | 176.13M | 142.94M |
Gross Profit Ratio | 46.02% | 43.13% | 44.53% | 44.01% | 45.57% | 46.64% | 45.23% | 45.08% | 46.40% | 48.00% | 48.97% | 50.34% | 51.97% | 56.32% | 60.10% | 56.85% | 52.59% | 48.67% | 36.35% | 32.32% | 30.68% | 30.26% | 25.51% |
Research & Development | 149.07M | 113.82M | 108.72M | 104.06M | 105.36M | 84.09M | 67.00M | 61.86M | 64.69M | 48.23M | 36.79M | 32.98M | 14.64M | 10.61M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 63.89M | 67.65M | 74.99M | 69.79M | 55.81M | 41.77M | 43.72M | 41.38M | 38.27M | 33.89M | 31.45M | 31.14M | 26.73M | 20.06M | 71.00M | 59.10M | 54.29M | 57.58M | 49.12M | 44.37M | 43.65M | 37.31M | 29.03M |
Selling & Marketing | 569.15M | 911.58M | 888.30M | 894.86M | 938.86M | 994.17M | 942.52M | 861.90M | 801.83M | 724.88M | 624.39M | 508.75M | 428.56M | 379.74M | 321.08M | 275.45M | 221.32M | 173.99M | 124.44M | 98.61M | 94.70M | 77.73M | 61.07M |
SG&A | 1.18B | 979.23M | 963.29M | 964.64M | 994.67M | 1.04B | 986.24M | 903.28M | 840.10M | 758.77M | 655.84M | 539.89M | 455.29M | 399.80M | 392.08M | 334.54M | 275.62M | 231.57M | 173.56M | 142.99M | 138.35M | 115.04M | 90.10M |
Other Expenses | -47.51M | 218.61M | 189.11M | 156.08M | 147.75M | 14.91M | -9.71M | 13.56M | 14.95M | 10.55M | 3.72M | 726.27K | 1.61M | 8.09M | 1.66M | -1.13M | 133.04K | 1.24M | 1.31M | 1.76M | -801.33K | -938.57K | -1.96M |
Operating Expenses | 1.29B | 1.31B | 1.26B | 1.22B | 1.25B | 1.25B | 1.17B | 1.11B | 1.04B | 924.33M | 810.39M | 663.73M | 536.54M | 473.97M | 404.50M | 345.25M | 282.90M | 237.69M | 178.01M | 146.34M | 142.32M | 118.10M | 92.85M |
Cost & Expenses | 3.34B | 3.60B | 3.29B | 3.26B | 3.17B | 3.03B | 2.91B | 2.68B | 2.35B | 2.07B | 1.82B | 1.45B | 1.14B | 901.83M | 765.33M | 691.04M | 605.20M | 547.05M | 601.80M | 555.73M | 618.42M | 524.00M | 510.13M |
Interest Income | 51.39M | 9.76M | 11.95M | 30.37M | 38.61M | 20.87M | 11.75M | 10.89M | 4.61M | 1.25M | 230.71K | 1.68M | 4.09M | 1.58M | 0.00 | 1.91M | -0.09 | 2.36M | 1.78M | 3.68M | 1.94M | 1.58M | 1.71M |
Interest Expense | 5.96M | 2.21M | 2.11M | 2.25M | 416.40K | 747.26K | 2.59M | 2.85M | 6.52M | 6.14M | 4.15M | 2.14M | 186.79K | 80.69K | 0.00 | -345.00 | 724.11K | 1.05M | 139.15K | 1.18M | 2.26M | 1.08M | 276.78K |
Depreciation & Amortization | 103.65M | 112.40M | 102.16M | 76.77M | 70.49M | 66.43M | 66.12M | 53.54M | 50.37M | 48.47M | 48.25M | 40.02M | 38.28M | 35.97M | 25.22M | 21.77M | 20.91M | 24.26M | 23.33M | 21.99M | 18.33M | 13.06M | -1.89M |
EBITDA | 565.74M | 568.28M | 541.07M | 504.28M | 501.37M | 420.89M | 356.22M | 263.99M | 169.31M | 198.12M | 205.25M | 197.60M | 148.12M | 150.02M | 165.10M | 132.15M | 95.49M | 109.64M | 97.81M | 79.53M | 90.71M | 73.44M | 50.02M |
EBITDA Ratio | 14.89% | 13.62% | 13.20% | 13.36% | 13.38% | 12.54% | 11.08% | 9.21% | 6.94% | 8.84% | 10.77% | 11.80% | 12.78% | 15.19% | 18.26% | 22.60% | 11.77% | 18.19% | 14.69% | 13.15% | 13.21% | 12.62% | 8.93% |
Operating Income | 461.94M | 444.25M | 436.23M | 424.18M | 430.78M | 337.39M | 296.35M | 193.95M | 94.76M | 130.41M | 149.99M | 150.89M | 108.08M | 101.53M | 155.24M | 143.05M | 198.89M | 83.88M | 74.27M | 55.26M | 71.47M | 60.23M | 51.90M |
Operating Income Ratio | 12.16% | 11.03% | 11.91% | 11.70% | 12.22% | 10.14% | 9.31% | 6.77% | 3.87% | 5.94% | 7.60% | 9.53% | 8.60% | 10.37% | 17.17% | 17.85% | 29.26% | 13.92% | 11.15% | 9.13% | 10.41% | 10.35% | 9.26% |
Total Other Income/Expenses | -1.52M | 1.57M | -2.81M | 406.33K | -1.08M | 14.91M | -9.71M | 12.43M | 14.84M | 10.00M | 2.86M | 399.43K | 1.57M | 27.76M | 17.41M | 31.45M | 123.30M | 441.01K | 9.06M | 6.51M | -1.34M | -933.25K | -2.16M |
Income Before Tax | 460.42M | 445.81M | 433.42M | 424.58M | 429.70M | 352.30M | 286.64M | 206.38M | 109.60M | 140.42M | 152.85M | 151.29M | 109.65M | 109.54M | 156.06M | 141.83M | 197.87M | 84.32M | 74.33M | 56.36M | 70.12M | 59.29M | 49.74M |
Income Before Tax Ratio | 12.12% | 11.07% | 11.83% | 11.71% | 12.19% | 10.58% | 9.01% | 7.20% | 4.48% | 6.40% | 7.75% | 9.55% | 8.73% | 11.18% | 17.26% | 17.70% | 29.11% | 13.99% | 11.16% | 9.32% | 10.21% | 10.19% | 8.88% |
Income Tax Expense | 65.40M | 57.55M | 58.68M | 64.38M | 77.60M | 49.75M | 39.98M | 33.02M | 21.26M | 22.72M | 24.07M | 20.38M | 14.88M | 11.96M | 19.15M | 7.34M | 21.28M | 9.36M | 12.61M | 9.78M | 21.69M | 20.35M | 14.39M |
Net Income | 320.41M | 302.51M | 302.06M | 297.07M | 294.31M | 255.36M | 207.76M | 149.43M | 92.96M | 105.09M | 123.77M | 120.16M | 82.82M | 86.38M | 130.91M | 129.89M | 173.62M | 71.78M | 59.86M | 45.39M | 50.07M | 39.75M | 34.49M |
Net Income Ratio | 8.44% | 7.51% | 8.24% | 8.19% | 8.35% | 7.67% | 6.53% | 5.22% | 3.80% | 4.79% | 6.27% | 7.59% | 6.59% | 8.82% | 14.48% | 16.21% | 25.54% | 11.91% | 8.99% | 7.50% | 7.29% | 6.83% | 6.16% |
EPS | 0.76 | 0.73 | 0.72 | 0.71 | 0.70 | 0.61 | 0.50 | 0.36 | 0.24 | 0.29 | 0.34 | 0.33 | 0.23 | 0.24 | 0.36 | 0.36 | 0.47 | 0.30 | 0.14 | 0.11 | 0.18 | 0.13 | 0.11 |
EPS Diluted | 0.76 | 0.73 | 0.72 | 0.71 | 0.70 | 0.61 | 0.50 | 0.36 | 0.24 | 0.29 | 0.34 | 0.33 | 0.23 | 0.24 | 0.36 | 0.36 | 0.47 | 0.30 | 0.14 | 0.11 | 0.18 | 0.13 | 0.11 |
Weighted Avg Shares Out | 422.53M | 418.51M | 418.51M | 418.51M | 418.51M | 418.48M | 418.51M | 418.45M | 383.34M | 365.75M | 365.82M | 365.80M | 365.79M | 365.77M | 365.76M | 365.77M | 365.78M | 304.83M | 304.83M | 304.83M | 304.83M | 304.83M | 304.83M |
Weighted Avg Shares Out (Dil) | 422.53M | 418.51M | 418.51M | 418.51M | 418.51M | 418.48M | 418.53M | 418.47M | 383.34M | 365.75M | 365.82M | 365.80M | 365.79M | 365.77M | 365.76M | 365.77M | 365.78M | 304.83M | 304.83M | 304.83M | 304.83M | 304.83M | 304.83M |
Source: https://incomestatements.info
Category: Stock Reports